Adriana Wawer

Dr. Adriana Wawer

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
KBKamilla Blecharz-Klin
Kamilla Blecharz-Klin
AWAdriana Wawer
Adriana Wawer
KJKatarzyna Jawna-Zboińska
Katarzyna Jawna-Zboińska
JPJustyna Pyrzanowska
Justyna Pyrzanowska
APAgnieszka Piechal
Agnieszka Piechal
EWEwa Widy-Tyszkiewicz
Ewa Widy-Tyszkiewicz

27 January 2016 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
KJKatarzyna Jawna‐Zboińska
Katarzyna Jawna‐Zboińska
KBKamilla Blecharz-Klin
Kamilla Blecharz-Klin
IJIlona Joniec-Maciejak
Ilona Joniec-Maciejak
AWAdriana Wawer
Adriana Wawer
JPJustyna Pyrzanowska
Justyna Pyrzanowska
EWEwa Widy-Tyszkiewicz
Ewa Widy-Tyszkiewicz

1 April 2017 in Behavioural Brain Research
Verified
Journal Article
Closed access
KBKamilla Blecharz-Klin
Kamilla Blecharz-Klin
APAgnieszka Piechal
Agnieszka Piechal
KJKatarzyna Jawna-Zboińska
Katarzyna Jawna-Zboińska
JPJustyna Pyrzanowska
Justyna Pyrzanowska
AWAdriana Wawer
Adriana Wawer
EWEwa Widy-Tyszkiewicz
Ewa Widy-Tyszkiewicz

1 April 2017 in Pharmacological Reports
Verified
Journal Article
Closed access
ASAnna Sznejder-Pachołek
Anna Sznejder-Pachołek
IJIlona Joniec-Maciejak
Ilona Joniec-Maciejak
AWAdriana Wawer
Adriana Wawer
ACAgnieszka Ciesielska
Agnieszka Ciesielska
DMDagmara M. Mirowska-Guzel
Dagmara M. Mirowska-Guzel

1 August 2014 in Pharmacological Reports
Verified
Journal Article
Closed access
IJIlona Joniec-Maciejak
Ilona Joniec-Maciejak
ACAgnieszka Ciesielska
Agnieszka Ciesielska
AWAdriana Wawer
Adriana Wawer
ASAnna Sznejder-Pachołek
Anna Sznejder-Pachołek
JSJoanna Schwenkgrub
Joanna Schwenkgrub
ACAndrzej Członkowski
Andrzej Członkowski

23 July 2013 in Neurochemical Research
Verified
Journal Article
Open access
PDF file
APAdam Przybyłkowski
Adam Przybyłkowski
Grażyna GromadzkaGrażyna Gromadzka
Grażyna Gromadzka
AWAdriana Wawer
Adriana Wawer
EBEwa Bulska
Ewa Bulska
KJKatarzyna Jabłonka-Salach
Katarzyna Jabłonka-Salach
ACAndrzej Członkowski
Andrzej Członkowski
Toxic milk mice have an inherited defect of copper metabolism. Hepatic phenotype of the toxic milk mice is similar to clinical findings in humans suffering from Wilson’s disease (WND). In the present study, neurotransmitter system and locomotor performance in toxic milk mice was examined to verify the feasibility of this animal model for studying neuropathology of WND. Mice aged 2 and 12 months were used in the experiment. The mice were tested according to rotarod and footprint protocols. Monoamine content in brain structures was measured by high performance liquid chromatography. In order to detect neuronal loss, expression of enzymes specific for dopaminergic [tyrosine hydroxylase (TH)], noradrenergic (dopamine beta-hydroxylase) and serotoninergic [tryptophan hydroxylase (TPH)] neurons was analyzed by Western blot. The 12-month-old toxic milk mice demonstrated impaired locomotor performance in behavioral tests. Motor deficits were accompanied by increased copper and serotonin content in different brain regions and slight decrease in dopamine concentration in the striatum. The expression of TH, dopamine beta-hydroxylase and TPH in the various brain structures did not differ between toxic milk mice and control animals. Despite differences in brain pathology between humans and rodents, further exploration of neuronal injury in toxic milk mice is warranted to broaden the understanding of neuropathology in WND.